Código 300670 (Harmonized System 2012 by 6 digits)
2023: US$39.4M, Total Trade Exchange
2023: US$12.5M, International Sales
2023: US$26.9M, International Purchases
In 2023, the trade exchange (includes international purchases and sales) of Preparations in Gel Form, Designed to be Used in Human or Veterinary Medicine as a Lubricant for Parts of the Body for Surgical Operations or Physical Examinations or as a Coupling Tests between the Body and Medical Instruments was US$39.4M.
In 2023, the states with the most international sales in Preparations in Gel Form, Designed to be Used in Human or Veterinary Medicine as a Lubricant for Parts of the Body for Surgical Operations or Physical Examinations or as a Coupling Tests between the Body and Medical Instruments were Sonora (US$5.51M), Baja California (US$560k), and Ciudad de México (US$244k).
The states with the most international purchases in 2023 were Tamaulipas (US$8.95M), Chihuahua (US$6.33M), Sonora (US$5.41M), Baja California (US$4.13M), and Ciudad de México (US$1.65M).
In 2023, the main commercial destinations of Preparations in Gel Form, Designed to be Used in Human or Veterinary Medicine as a Lubricant for Parts of the Body for Surgical Operations or Physical Examinations or as a Coupling Tests between the Body and Medical Instruments were United States (US$6.06M), Guatemala (US$121k), Costa Rica (US$43.9k), Venezuela (US$35.7k), and Dominican Republic (US$15.8k).
The main commercial origins of Preparations in Gel Form, Designed to be Used in Human or Veterinary Medicine as a Lubricant for Parts of the Body for Surgical Operations or Physical Examinations or as a Coupling Tests between the Body and Medical Instruments in 2023 were United States (US$19.9M), United Kingdom (US$2.33M), Dominican Republic (US$1.53M), China (US$1.07M), and Thailand (US$686k).
In the global context, the main exporting countries of Preparations in Gel Form, Designed to be Used in Human or Veterinary Medicine as a Lubricant for Parts of the Body for Surgical Operations or Physical Examinations or as a Coupling Tests between the Body and Medical Instruments in 2022 were United States (US$87M), Ireland (US$40.5M), and China (US$33M). In the same year, the main importing countries of Preparations in Gel Form, Designed to be Used in Human or Veterinary Medicine as a Lubricant for Parts of the Body for Surgical Operations or Physical Examinations or as a Coupling Tests between the Body and Medical Instruments were United States (US$45.8M), Netherlands (US$28.8M), and Mexico (US$20.8M).
US$39.4M, Total Trade Exchange (2023)
In 2023, the total trade exchange of Preparations in Gel Form, Designed to be Used in Human or Veterinary Medicine as a Lubricant for Parts of the Body for Surgical Operations or Physical Examinations or as a Coupling Tests between the Body and Medical Instruments in Mexico (including international purchases and sales) was US$39.4M.
The visualizations show the net balance of Preparations in Gel Form, Designed to be Used in Human or Veterinary Medicine as a Lubricant for Parts of the Body for Surgical Operations or Physical Examinations or as a Coupling Tests between the Body and Medical Instruments at the level of states and countries. Colors more similar to blue, indicate that the territory presented a higher level of international sales. Colors more similar to red, indicate that the territory presented a higher level of international purchases.
November, 2024
In November 2024, international sales of Preparations in Gel Form, Designed to be Used in Human or Veterinary Medicine as a Lubricant for Parts of the Body for Surgical Operations or Physical Examinations or as a Coupling Tests between the Body and Medical Instruments were US$1.64M, while international purchases reached US$2.59M. The above results in a trade balance of -US$956k.
2024-Q4: US$1.55M, International Sales
The visualization shows the quarterly concentration of international sales of Preparations in Gel Form, Designed to be Used in Human or Veterinary Medicine as a Lubricant for Parts of the Body for Surgical Operations or Physical Examinations or as a Coupling Tests between the Body and Medical Instruments at state level.
In the fourth quarter of 2024, international sales were US$1.55M, being the states with the most sales Tamaulipas (US$980k), Sonora (US$565k), and Baja California (US$7.38k).
Sonora: US$5.51M, State with the Most International Sales (2023)
United States: US$6.06M, Main commercial destination (2023)
In 2023, the states with the highest international sales in Preparations in Gel Form, Designed to be Used in Human or Veterinary Medicine as a Lubricant for Parts of the Body for Surgical Operations or Physical Examinations or as a Coupling Tests between the Body and Medical Instruments were Sonora (US$5.51M), Baja California (US$560k), and Ciudad de México (US$244k).
In 2023, the countries with the most international purchases from Mexico were United States (US$6.06M), Guatemala (US$121k), Costa Rica (US$43.9k), Venezuela (US$35.7k), and Dominican Republic (US$15.8k).
Tamaulipas: US$8.95M, State with the Most International Purchases (2023)
United States: US$19.9M, Main Commercial Origin (2023)
In 2023, the states with the highest international in Preparations in Gel Form, Designed to be Used in Human or Veterinary Medicine as a Lubricant for Parts of the Body for Surgical Operations or Physical Examinations or as a Coupling Tests between the Body and Medical Instruments were Tamaulipas (US$8.95M), Chihuahua (US$6.33M), Sonora (US$5.41M), Baja California (US$4.13M), and Ciudad de México (US$1.65M).
The countries with the most international sales to Mexico in 2023 were United States (US$19.9M), United Kingdom (US$2.33M), Dominican Republic (US$1.53M), China (US$1.07M), and Thailand (US$686k).
The RCA-Complexity diagram compares the Revelead Comparative Advantages of states in Preparations in Gel Form, Designed to be Used in Human or Veterinary Medicine as a Lubricant for Parts of the Body for Surgical Operations or Physical Examinations or as a Coupling Tests between the Body and Medical Instruments and the Economic Complexity Index of each state.
RCA values greater than 1 indicate that the state has comparative advantages in Preparations in Gel Form, Designed to be Used in Human or Veterinary Medicine as a Lubricant for Parts of the Body for Surgical Operations or Physical Examinations or as a Coupling Tests between the Body and Medical Instruments. On the other hand, high levels of complexity (ECI) are associated with higher levels of income, potential for economic growth, lower income inequality and lower emissions.
The visualizations show the global market for Preparations in Gel Form, Designed to be Used in Human or Veterinary Medicine as a Lubricant for Parts of the Body for Surgical Operations or Physical Examinations or as a Coupling Tests between the Body and Medical Instruments. In both charts, Mexico stands out in order to identify its participation in the export and import market.
In 2022, the main exporting countries of Preparations in Gel Form, Designed to be Used in Human or Veterinary Medicine as a Lubricant for Parts of the Body for Surgical Operations or Physical Examinations or as a Coupling Tests between the Body and Medical Instruments were United States (US$87M), Ireland (US$40.5M), and China (US$33M). In the same year, the main importing countries for Preparations in Gel Form, Designed to be Used in Human or Veterinary Medicine as a Lubricant for Parts of the Body for Surgical Operations or Physical Examinations or as a Coupling Tests between the Body and Medical Instruments were United States (US$45.8M), Netherlands (US$28.8M), and Mexico (US$20.8M).